secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001641489-23-000085
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics receives Nasdaq delisting notice for MVLS non-compliance
-------------------------------------------------------------------------

- Nasdaq notified vTv on Dec 13, 2023 that MVLS was below $35M for 30 consecutive business days.
- Company has 180 calendar days, until June 10, 2024, to regain compliance.
- To regain compliance, MVLS must close at $35M or more for 10 consecutive business days.
- Failure to cure may result in delisting of Class A common stock from Nasdaq Capital Market.
- Company is evaluating options but offers no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000085/0001641489-23-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000085/vtvt-20231213.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer